Epilepsy in the cancer patient

Cancer Chemotherapy and Pharmacology

Volumn 67, Issue 3, 2011, Pages 489-501

  Kargiotis, Odysseas ^a,b   Markoula, Sofia ^c   Kyritsis, Athanasios P ^a,c  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Antiepileptics, chemotherapy; Cancer; Levetiracetam; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CARBAMAZEPINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ERLOTINIB; ETIRACETAM; ETOPOSIDE; FLUOROURACIL; GABAPENTIN; IFOSFAMIDE; IMATINIB; IRINOTECAN; IXABEPILONE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; PROCARBAZINE; TIAGABINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADD ON THERAPY; ANTICONVULSANT THERAPY; ANTIEMETIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; BRAIN DISEASE; BRAIN METASTASIS; BRAIN TUMOR; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER INVASION; CANCER PATIENT; CARCINOMATOUS MENINGITIS; CENTRAL NERVOUS SYSTEM INFECTION; COGNITIVE DEFECT; COLORECTAL CANCER; DISEASE CONTROL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG POTENCY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG TOLERANCE; ELECTROLYTE DISTURBANCE; EPILEPSY; ERYTHEMA MULTIFORME; FOCAL EPILEPSY; GLIOBLASTOMA; GLIOMA; HEMATOLOGIC DISEASE; HUMAN; HYPOGLYCEMIA; HYPOXIA; INSOMNIA; LEUKOPENIA; LIVER FAILURE; LUNG CANCER; LYMPHOMA; MALIGNANT MENINGIOMA; MAXIMUM TOLERATED DOSE; MEDULLOBLASTOMA; MELANOMA; MENINGIOMA; METABOLIC DISORDER; MONOTHERAPY; NEUROBLASTOMA; OPTIMAL DRUG DOSE; PARANEOPLASTIC SYNDROME; PRIMARY TUMOR; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; REVIEW; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SYMPTOMATIC EPILEPSY; THROMBOCYTOPENIA; TREATMENT DURATION; TUMOR GROWTH; ANIMAL; DRUG COMBINATION; DRUG INTERACTION; METASTASIS; PATHOLOGY;

ANIMALS; ANTICONVULSANTS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EPILEPSY; HUMANS;

EID: 79953798775     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-011-1569-0     Document Type: Review

References (90)

1. J Grewal HK Grewal AD Forman 2008 Seizures and epilepsy in cancer: etiologies, evaluation, and management Curr Oncol Rep 10 63 71 10.1007/s11912-008-0010-2 18366962
2. ST Herman 2002 Epilepsy after brain insult: targeting epileptogenesis Neurology 59 (Suppl) S21 S26
3. MS van Breemen EB Wilms CJ Vecht 2007 Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management Lancet Neurols 6 421 430 10.1016/S1474-4422(07)70103-5 (Pubitemid 46551867)
4. EB Bromfield 2004 Epilepsy in patients with brain tumors and other cancers Rev Neurol Dis 1(suppl 1) S27 S33
5. C Sioka A Fotopoulos AP Kyritsis 2010 Paraneoplastic neurological syndromes and the role of PET imaging Oncology 78 150 156 10.1159/000312657 20389137
6. V Villanueva M Codina E Elices 2008 Management of epilepsy in oncological patients Neurologist 14 6 (Suppl 1) S44 S54 10.1097/01.nrl.0000340791.53413.f4 19225370
7. C Sioka AP Kyritsis 2009 Central and peripheral nervous system toxicity of common chemotherapeutic agents Cancer Chemother Pharmacol 63 761 767 1:CAS:528:DC%2BD1MXitlWhtrY%3D 10.1007/s00280-008-0876-6 19034447
8. PY Wen PW Marks 2002 Medical management of patients with brain tumors Curr Opin Oncol 14 299 307 10.1097/00001622-200205000-00008 11981275 (Pubitemid 34492862)
9. MF Samji EC Fric-Shamji BG Benoit 2009 Brain tumors and epilepsy: pathophysiology of peritumoral changes Neurosurg Rev 32 275 285 10.1007/s10143-009-0191-7
10. PL Moots RJ Maciunas DR Eisert RA Parker K Laporte B Abou-Khalil 1995 The course of seizure disorders in patients with malignant gliomas Arch Neurol 52 717 724 1:STN:280:DyaK2MzksVensg%3D%3D 7619029
11. A Pace L Bove P Innocenti A Pietrangeli CM Carapella P Oppido L Raus E Occhipinti B Jandolo 1998 Epilepsy and gliomas: incidence and treatment in 119 patients J Exp Clin Cancer Res. 17 479 482 1:STN:280:DyaK1M7os12gsA%3D%3D 10089071 (Pubitemid 29083423)
12. JG Villemure N de Tribolet 1996 Epilepsy in patients with central nervous system tumors Curr Opin Neurol 9 424 428 1:STN:280:DyaK2s7lvFyrsQ%3D%3D 10.1097/00019052-199612000-00005 9007399 (Pubitemid 27042602)
13. AS Lieu SL Howng 2000 Intracranial meningiomas and epilepsy: incidence, prognosis and influencing factors Epilepsy Res 38 45 52 1:STN:280: DC%2BD3c%2FmvVWjtw%3D%3D 10.1016/S0920-1211(99)00066-2 10604605
14. MJ Glantz BF Cole PA Forsyth LD Recht PY Wen MC Chamberlain SA Grossman JG Cairncross 2000 Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumours. Reported of the Quality Standard Subcommittee of the American Academy of Neurology Neurology 54 1886 1893 1:STN:280:DC%2BD3c3osVWhsA%3D%3D 10822423 (Pubitemid 30327107)
15. A Liigant S Haldre A Oun U Linnamagi A Saar T Asser AE Kaasik 2001 Seizure disorders in patients with brain tumors Eur Neurol 45 46 51 1:STN:280:DC%2BD3M7lsFamtA%3D%3D 10.1159/000052089 11150841 (Pubitemid 32041387)
16. KF Rajneesh DK Binder 2009 Tumor-associated epilepsy Neurosurg Focus 27 E4 10.3171/2009.5.FOCUS09101 19645560
17. A Beaumont IR Whittle 2000 The pathogenesis of tumour associated epilepsy Acta Neurochir (Wien) 142 1 15 1:STN:280:DC%2BD3c7ivFeksA%3D%3D 10.1007/s007010050001 (Pubitemid 30068270)
18. D Kurzwelly U Herrlinger M Simon 2010 Seizures in patients with low-grade gliomas-incidence, pathogenesis, surgical management, and pharmacotherapy Adv Tech Stand Neurosurg 35 81 111 1:STN:280:DC%2BC3c%2FlsV2ktA%3D%3D 10.1007/978-3-211-99481-8-4 20102112
19. B Schaller 2005 Influences of brain tumor-associated pH changes and hypoxia on epileptogenesis Acta Neurol Scand 111 75 83 1:CAS:528: DC%2BD2MXhvFGjsbY%3D 10.1111/j.1600-0404.2004.00355.x 15644065 (Pubitemid 40175328)
20. E Kim JD Lowenson DC MacLaren S Clarke SG Young 1997 Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice Proc Natl Acad Sci USA 94 6132 6137 1:CAS:528:DyaK2sXjvFCntrc%3D 10.1073/pnas.94.12.6132 9177182 (Pubitemid 27270649)
21. E Aronica JA Gorter GH Jansen S Leenstra B Yankaya D Troost 2001 Expression of connexin 43 and connexin 32 gapjunction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex Acta Neuropathol 101 449 459 1:CAS:528:DC%2BD3MXktVGmsLg%3D 11484816 (Pubitemid 32600134)
22. DE Bateman JA Hardy JR McDermott DS Parker JA Edwardson 1988 Amino acid neurotransmitter levels in gliomas and their relationship to the incidence of epilepsy Neurol Res 10 112 114 1:CAS:528:DyaL1cXlt1Klur4%3D 2902524
23. S Maas S Patt M Schrey A Rich 2001 Underediting of glutamate receptor GluR-B mRNA in malignant gliomas Proc Natl Acad Sci USA 98 14687 14692 1:CAS:528:DC%2BD3MXptFCksbk%3D 10.1073/pnas.251531398 11717408 (Pubitemid 33121452)
24. I Mody U Heinemann 1987 NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling Nature 326 701 704 1:CAS:528:DyaL2sXitVygsbo%3D 10.1038/326701a0 3031511 (Pubitemid 17059790)
25. V Siomin L Angelov L Li MA Vogelbaum 2005 Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors J Neurooncol 74 211 215 1:CAS:528: DC%2BD2MXht12hurjK 10.1007/s11060-004-6912-4 16193395 (Pubitemid 41478921)
26. JI Sirven DM Wingerchuk JF Drazkowski MK Lyons RS Zimmerman 2004 Seizure prophylaxis in patients with brain tumors: a metanalysis Mayo Clin Proc 79 1489 1494 10.4065/79.12.1489 15595331 (Pubitemid 39578871)
27. A Rosati A Tomassini B Pollo C Ambrosi A Schwarz A Padovani B Bonetti 2009 Epilepsy in cerebral glioma: timing of appearance and histological correlations J Neurooncol 93 395 400 10.1007/s11060-009-9796-5 19183850
28. Tremont-Lukats IW, Ratilal BO, Armstrong T, Gilbert MR (2008) Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database Syst Rev. 16:CD004424. Review
29. PA Forsyth S Weaver D Fulton PM Brasher G Sutherland D Stewart NA Hagen P Barnes JG Cairncross LM DeAngelis 2003 Prophylactic anticonvulsants in patients with brain tumour Can J Neurol Sci 30 106 112 12774949 (Pubitemid 36717992)
30. T Mikkelsen NA Paleologos PD Robinson M Ammirati DW Andrews AL Asher SH Burri CS Cobbs LE Gaspar D Kondziolka ME Linskey JS Loeffler M McDermott MP Mehta JJ Olson RA Patchell TC Ryken SN Kalkanis 2010 The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline J Neurooncol 96 97 102 10.1007/s11060-009-0056-5 19957015
31. MD Shaw 1990 Post-operative epilepsy and the efficacy of anticonvulsant therapy Acta Neurochir Suppl (Wien) 50 55 57 1:STN:280:DyaK3M3nt1yrtw%3D%3D
32. S Franceschetti S Binelli M Casazza S Lodrini F Panzica F Pluchino CL Solero G Avanzini 1990 Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours Acta Neurochir (Wien) 103 47 51 1:STN:280:DyaK3c3ps12ntw%3D%3D 10.1007/BF01420191 (Pubitemid 20155189)
33. AM Mauro C Bomprezzi S Morresi L Provinciali F Formica M Iacoangeli M Scerrati 2007 Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepine J Neurooncol 81 279 285 1:CAS:528:DC%2BD2sXktFWhtb4%3D 10.1007/s11060-006-9229-7 16944312 (Pubitemid 46165332)
34. Zachenhofer I, Donat M, Oberndorfer S, Roessler K (2010) Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery. J Neurooncol [Epub ahead of print]
35. A De Santis R Villani M Sinisi N Stocchetti E Perucca 2002 Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study Epilepsia 43 175 182 10.1046/j.1528-1157. 2002.24801.x 11903465 (Pubitemid 34225999)
36. BA Lynch N Lambeng K Nocka P Kensel-Hammes SM Bajjalieh A Matagne B Fuks 2004 The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam Proc Natl Acad Sci USA 101 9861 9866 1:CAS:528: DC%2BD2cXlvVahtb8%3D 10.1073/pnas.0308208101 15210974 (Pubitemid 38869327)
37. L Dinapoli M Maschio B Jandolo A Fabi A Pace F Sperati P Muti 2009 Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study Neurol Sci 30 353 359 10.1007/s10072-009-0087-x
38. DA Lim P Tarapore E Chang M Burt L Chakalian N Barbaro S Chang KR Lamborn MW McDermott 2009 Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II study J Neurooncol 93 349 354 1:CAS:528:DC%2BD1MXmsVClsb4%3D 10.1007/s11060-008-9781-4 19169651
39. Usery JB, Michael LM 2nd, Sills AK, Finch CK (2010) A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures. J Neurooncol. [Epub ahead of print]
40. HB Newton J Dalton S Goldlust D Pearl 2007 Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors J Neurooncol 84 293 296 1:CAS:528:DC%2BD2sXhtVWqtr%2FP 10.1007/s11060-007-9373-8 17431542
41. HB Newton SA Goldlust D Pearl 2006 Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients J Neurooncol 78 99 102 1:CAS:528:DC%2BD28XotFeit7k%3D 10.1007/s11060-005-9070-4 16541329 (Pubitemid 43786667)
42. M Maschio F Albani A Baruzzi A Zarabla L Dinapoli A Pace A Pompili CM Carapella E Occhipinti B Jandolo 2006 Levetiracetam therapy in patients with brain tumour and epilepsy J Neurooncol 80 97 100 1:CAS:528:DC%2BD28Xht12qtLvP 10.1007/s11060-006-9162-9 16685465 (Pubitemid 44473268)
43. JW Lee EB Bromfield S Kesari 2008 Antiemetic properties of the antiepileptic drug levetiracetam N Engl J Med 359 1853 1:CAS:528: DC%2BD1cXht12msrnE 10.1056/NEJMc0806761 18946077
44. MS van Breemen RM Rijsman MJ Taphoorn R Walchenbach H Zwinkels CJ Vecht 2009 Efficacy of anti-epileptic drugs in patients with gliomas and seizures J Neurol 256 1519 1526 10.1007/s00415-009-5156-9 19434440
45. M Maschio L Dinapoli A Zarabla A Pompili CM Carapella A Pace D Giannarelli E Occhipinti B Jandolo 2008 Outcome and tolerability of topiramate in brain tumor associated epilepsy J Neurooncol 86 61 70 1:STN:280: DC%2BD2sjhsFSmug%3D%3D 10.1007/s11060-007-9430-3 17598071 (Pubitemid 350263434)
46. M Maschio L Dinapoli A Vidiri A Pace A Fabi A Pompili MC Carapella B Jandolo 2009 The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine J Exp Clin Cancer Res 28 60 10.1186/1756-9966-28-60 19419544
47. CJ Vecht EB Wilms 2010 Seizures in low- and high-grade gliomas: current management and future outlook Expert Rev Anticancer Ther 10 663 669 10.1586/era.10.48 20469999
48. JR Perry C Sawka 1996 Add-on gabapentin for refractory seizures in patients with brain tumours Can J Neurol Sci 23 128 131 1:STN:280: DyaK28zivVGqtg%3D%3D 8738926 (Pubitemid 26186481)
49. S Striano P Striano P Boccella C Nocerino L Bilo 2002 Tiagabine in glial tumors Epilepsy Res 49 81 85 1:CAS:528:DC%2BD38Xis1ensbc%3D 10.1016/S0920- 1211(02)00005-0 11948010 (Pubitemid 34304209)
50. J Novy R Stupp AO Rossetti 2009 Pregabalin in patients with primary brain tumors and seizures: a preliminary observation Clin Neurol Neurosurg 111 171 173 10.1016/j.clineuro.2008.09.009 18977587
51. M Maschio L Dinapoli S Gomellini V Ferraresi F Sperati A Vidiri P Muti B Jandolo 2010 Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy J Neurooncol 98 109 116 1:CAS:528:DC%2BC3cXntVClu7w%3D 10.1007/s11060-009-0069-0 19937087
52. N Cohen G Strauss R Lew D Silver L Recht 1988 Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis J Clin Oncol 6 1621 1624 1:STN:280:DyaL1M%2FhtVyrsw%3D%3D 3171627 (Pubitemid 19092399)
53. DL Drane KJ Meador 2002 Cognitive and behavioral effects of antiepileptic drugs Epilepsy Behav 3 49 53 10.1016/S1525-5069(02)00502-9 12609322
54. J Delattre B Safai JB Posner 1988 Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin Neurology 38 194 198 1:STN:280:DyaL1c7itlSkuw%3D%3D 3340279 (Pubitemid 18036835)
55. HX Khe JY Delattre M Poisson 1990 Stevens-Johnson syndrome in a patient receiving cranial irradiation and carbamazepine Neurology 40 1144 1145 (Pubitemid 20213994)
56. HJ Mamon PY Wen AC Burns JS Loeffler 1999 Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy Epilepsia 40 341 344 1:STN:280:DyaK1M7nvVKjsw%3D%3D 10.1111/j.1528-1157.1999. tb00715.x 10080516 (Pubitemid 29164800)
57. D Aguiar R Pazo I Duran J Terrasa A Arrivi H Manzano J Martin J Rifa 2004 Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider J Neurooncol 66 345 350 10.1023/B:NEON. 0000014538.31561.bc 15015667 (Pubitemid 38258350)
58. M Klein JJ Heimans NK Aaronson HM van der Ploeg J Grit M Muller TJ Postma JJ Mooij RH Boerman GN Beute GJ Ossenkoppele GW van Imhoff AW Dekker J Jolles BJ Slotman H Struikmans MJ Taphoorn 2002 Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study Lancet 360 1361 1368 1:STN:280: DC%2BD38nmsVWmsg%3D%3D 10.1016/S0140-6736(02)11398-5 12423981 (Pubitemid 35341299)
59. E Perucca 2006 Clinically relevant drug interactions with antiepileptic drugs Br J Clin Pharmacol 61 246 255 1:CAS:528:DC%2BD28XislKhsLs%3D 10.1111/j.1365-2125.2005.02529.x 16487217 (Pubitemid 43382623)
60. KY Yap WK Chui A Chan 2008 Drug interactions between chemotherapeutic regimens and antiepileptics Clin Ther 30 1385 1407 1:CAS:528:DC%2BD1cXhtF2rtLfI 10.1016/j.clinthera.2008.08.011 18803983
61. CJ Vecht GL Wagner EB Wilms 2003 Interactions between antiepileptic and chemotherapeutic drugs Lancet Neurol 2 404 409 1:CAS:528:DC%2BD3sXms1yhsLk%3D 10.1016/S1474-4422(03)00435-6 12849118 (Pubitemid 36793932)
62. A Ruggiero D Rizzo S Mastrangelo D Battaglia G Attinà R Riccardi 2010 Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: is it time to change treatment? Pediatr Blood Cancer 54 193 198 19731334
63. S Pursche E Schleyer M von Bonin G Ehninger SM Said R Prondzinsky T Illmer Y Wang C Hosius Z Nikolova M Bornhäuser G Dresemann 2008 Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients Curr Clin Pharmacol 3 198 203 1:CAS:528: DC%2BD1MXitF2hsbc%3D 10.2174/157488408785747656 18781906
64. JJ Raizer LE Abrey AB Lassman SM Chang KR Lamborn JG Kuhn WK Yung MR Gilbert KD Aldape PY Wen HA Fine M Mehta LM Deangelis F Lieberman TF Cloughesy HI Robins J Dancey MD Prados North American Brain Tumor Consortium 2010 A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas Neuro Oncol 12 87 94 1:CAS:528:DC%2BC3cXjvFCntL8%3D 20150371
65. EK Avila J Graber 2010 Seizures and epilepsy in cancer patients Curr Neurol Neurosci Rep 10 60 67 10.1007/s11910-009-0080-z 20425228
66. SM Sisodiya 2003 Mechanisms of antiepileptic drug resistance Curr Opin Neurol 16 197 201 1:CAS:528:DC%2BD3sXmvFSnt74%3D 10.1097/00019052-200304000- 00013 12644749 (Pubitemid 36521207)
67. C Calatozzolo M Gelati E Ciusani FL Sciacca B Pollo L Cajola C Marras A Silvani L Vitellaro-Zuccarello D Croci A Boiardi A Salmaggi 2005 Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma J Neurooncol 74 113 121 1:CAS:528:DC%2BD2MXht12hurvF 10.1007/s11060-004-6152-7 16193381 (Pubitemid 41478906)
68. M Gottlicher S Minucci P Zhu OH Krämer A Schimpf S Giavara JP Sleeman F Lo Coco C Nervi PG Pelicci T Heinzel 2001 Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells EMBO J 20 6969 6978 1:CAS:528:DC%2BD38XpsFKn 10.1093/emboj/20.24.6969 11742974 (Pubitemid 34062289)
69. CJ Phiel F Zhang EY Huang MG Guenther MA Lazar PS Klein 2001 Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen J Biol Chem 276 36734 36741 1:CAS:528: DC%2BD3MXnt1yrurw%3D 10.1074/jbc.M101287200 11473107
70. A Duenas-Gonzalez M Candelaria C Perez-Plascencia E Perez-Cardenas E de la Cruz-Hernandez LA Herrera 2008 Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors Cancer Treat Rev 34 206 222 1:CAS:528:DC%2BD1cXls12qurs%3D 10.1016/j.ctrv.2007.11.003 18226465
71. JA Benítez L Arregui G Cabrera J Segovia 2008 Valproic acid induces polarization, neuronal-like differentiation of a subpopulation of C6 glioma cells and selectively regulates transgene expression Neuroscience 156 911 920 10.1016/j.neuroscience.2008.07.065 18771712
72. J Cinatl Jr R Kotchetkov R Blaheta PH Driever JU Vogel J Cinatl 2002 Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE (2)-C cells by valproic acid: enhancement by combination with interferon-alpha Int J Oncol 20 97 106 1:CAS:528:DC%2BD38XlvFeitw%3D%3D 11743648
73. S Häcker A Dittrich A Mohr T Schweitzer S Rutkowski J Krauss KM Debatin S Fulda 2009 Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8 Oncogene 28 3097 3110 10.1038/onc.2009.161 19597472
74. MM Knüpfer F Pulzer I Schindler P Hernaíz Driever H Knüpfer E Keller 2001 Different effects of valproic acid on proliferation and migration of malignant glioma cells in vitro Anticancer Res 21 347 351 11299760
75. CM Das D Aguilera H Vasquez P Prasad M Zhang JE Wolff V Gopalakrishnan 2007 Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines J Neurooncol 85 159 170 1:CAS:528:DC%2BD2sXhtl2gs73O 10.1007/s11060-007-9402-7 17534580 (Pubitemid 47629397)
76. XN Li Q Shu JM Su L Perlaky SM Blaney CC Lau 2005 Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC Mol Cancer Ther 4 1912 1922 1:CAS:528:DC%2BD2MXhtlCnsrvJ 10.1158/1535-7163.MCT- 05-0184 16373706 (Pubitemid 43056974)
77. V Venkataramani C Rossner L Iffland S Schweyer IY Tamboli J Walter O Wirths TA Bayer 2010 Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein J Biol Chem 285 10678 10689 1:CAS:528:DC%2BC3cXjvFaju7Y%3D 10.1074/jbc.M109.057836 20145244
78. A Papi AM Ferreri P Rocchi F Guerra M Orlandi 2010 Epigenetic modifiers as anticancer drugs: effectiveness of valproic acid in neural crest-derived tumor cells Anticancer Res 30 535 540 1:CAS:528:DC%2BC3cXksFCqs7c%3D 20332466
79. Q Shu B Antalffy JM Su A Adesina CN Ou T Pietsch SM Blaney CC Lau XN Li 2006 Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts Clin Cancer Res 12 4687 4694 1:CAS:528:DC%2BD28XnvVGksL0%3D 10.1158/1078-0432.CCR-05-2849 16899619 (Pubitemid 44297822)
80. E Ciusani M Balzarotti C Calatozzolo U de Grazia A Boiardi A Salmaggi D Croci 2007 Valproic acid increases the in vitro effects of nitrosureas on human glioma cell lines Oncol Res 16 453 463 1:CAS:528:DC%2BD1cXhtVCnsL8%3D 10.3727/096504007783338340 18196869
81. S Jawed B Kim T Ottenhof GM Brown ES Werstiuk LP Niles 2007 Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation Eur J Pharmacol 560 17 22 1:CAS:528:DC%2BD2sXisVWns7g%3D 10.1016/j.ejphar.2007.01.022 17303109
82. J Fu CJ Shao FR Chen HK Ng ZP Chen 2010 Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines Neuro Oncol 12 328 340 1:CAS:528:DC%2BC3cXotlCmsb0%3D 20308311
83. K Camphausen D Cerna T Scott M Sproull WE Burgan MA Cerra H Fine PJ Tofilon 2005 Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid Int J Cancer 114 380 386 1:CAS:528:DC%2BD2MXhvFKks7k%3D 10.1002/ijc.20774 15578701 (Pubitemid 40279957)
84. P Chinnaiyan D Cerna WE Burgan K Beam ES Williams K Camphausen PJ Tofilon 2008 Postradiation sensitization of the histone deacetylase inhibitor valproic acid Clin Cancer Res 14 5410 5415 1:CAS:528:DC%2BD1cXhtVKmsbvO 10.1158/1078-0432.CCR-08-0643 18765532
85. GC Bobustuc CH Baker A Limaye WD Jenkins G Pearl NG Avgeropoulos SD Konduri 2010 Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide Neuro Oncol 12 917 927 1:CAS:528: DC%2BC3cXhtVGrsbbP 10.1093/neuonc/noq044 20525765
86. JR Silber BA Mueller TG Ewers MS Berger 1993 Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain Cancer Res 53 3416 3420 1:CAS:528:DyaK3sXmtVSrsr8%3D 8324751 (Pubitemid 23223319)
87. ME Hegi AC Diserens T Gorlia MF Hamou N de Tribolet M Weller JM Kros JA Hainfellner W Mason L Mariani JE Bromberg P Hau RO Mirimanoff JG Cairncross RC Janzer R Stupp 2005 MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 997 1003 1:CAS:528:DC%2BD2MXit1Wktro%3D 10.1056/NEJMoa043331 15758010 (Pubitemid 40349502)
88. S Oberndorfer M Piribauer C Marosi H Lahrmann P Hitzenberger W Grisold 2005 P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy J Neurooncol 72 255 260 1:CAS:528:DC%2BD28Xltg%3D%3D 10.1007/s11060-004-2338-2 15937649 (Pubitemid 40867409)
89. KA Jaeckle K Ballman A Furth JC Buckner 2009 Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma Neurology 73 1207 1213 1:CAS:528:DC%2BD1MXht1antrfN 10.1212/WNL.0b013e3181bbfeca 19822870
90. MV Relling CH Pui JT Sandlund GK Rivera ML Hancock JM Boyett EG Schuetz WE Evans 2000 Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia Lancet 356 285 290 1:CAS:528:DC%2BD3cXlsVOqsro%3D 10.1016/S0140-6736(00)02503-4 11071183 (Pubitemid 30459586)